Proteinuria Flashcards
What are the three pathophysiological mechanisms which cause proteinuria?
- Glomerular
- Tubular
- Overflow
What are the features of nephritic syndrome?
- Haematuria
- Oliguria
- Proteinuria <3g/24grs
- Fluid retention
What are the features of nephrotic syndrome?
- Peripheral oedema
- Proteinuria >3g/24hrs
- Hypoalbuminaemia <25g/L
- Hypercholesterolaemia
Name the 3 types of non-proliferative glomerulonephritis (associated with nephrotic syndrome)
- Minimal change disease
- Focal segmental glomerulosclerosis
- Membranous glomerulonephritis
Name the 4 types of proliferative glomerulonephritis (associated with nephritic syndrome)
- IgA nephropathy
- Rapidly progressive glomerulonephritis (crescentic)
- Membranoproliferative (aka mesangiocapillary) glomerulonephritis
- Post infective glomerulonephritis
Describe minimal change disease
Minimal change glomerulonephritis (also called minimal change disease) presents with nephrotic syndrome and accounts for 80% of all nephrotic syndrome in children and 20% of nephrotic syndrome in adults.
The underlying cause of minimal change glomerulonephritis is unknown. The name minimal change glomerulonephritis comes from the lack of changes seen on light microscopy.
What is the management for minimal change disease?
Supportive care: nutritional support, salt and fluid restriction
Corticosteroids: first-line treatment in both adults and children (more data for efficacy in children) – usually prednisone
Other immunosuppressants (e.g. calcineurin inhibitor, mycophenolate mofetil, rituximab): these are second-line management options, and their effectiveness is unclear
Describe focal segmental glomerulosclerosis
Focal segmental glomerulosclerosis typically presents with nephrotic syndrome. It is the most common cause of nephrotic syndrome in adults.
It can be divided into primary FSGS (unknown cause with a possible genetic element) and secondary FSGS (caused by another disease process, e.g. HIV, lupus, reflux nephropathy).
Investigations:
Typical findings on renal biopsy are segmental scarring of some glomeruli and fusion of foot processes.
What is the management of FSGS?
Lifestyle changes
Supportive care: salt restriction diet and fluid management
High-dose prednisolone: approximately 50% of patients respond and treatment can be up to four months in adults. Steroids to suppress the immune system.
Blood pressure and cholesterol reducing medications.
Cyclophosphamide or ciclosporin is used in some cases to reduce proteinuria
In secondary FSGS treat the underlying cause.
Describe membranous glomerulonephritis
Slowly progressive disease primarily affecting individuals between the ages of 30 – 50.
Membranous glomerulonephritis is commonly idiopathic but can be associated with hepatitis B, malaria and systemic lupus erythematosus (SLE).
Immune complex deposition results in complement activation against glomerular basement membrane proteins.
Investigations - typical findings on renal biopsy include:
Microscopic analysis: shows thickened glomerular basement membrane
Immunofluorescence: shows diffuse uptake of IgG
What is the management of membranous glomerulonephritis?
Supportive care: salt restriction and fluid management
Corticosteroids are often used to treat progressive disease
Describe IgA nephropathy
IgA nephropathy is also known as Berger’s disease. It is the most common form of glomerulonephritis in adults worldwide. IgA antibodies have an abnormal structure so they accumulate in the kidney. Develops during infection involving mucosal lining ie. GI or resp –> causes increase in IgA which builds up in the kidney (deposit in mesangial area).
IgA nephropathy typically presents as nephritic syndrome (macroscopic haematuria), 24-48 hours after an upper respiratory tract infection.
Investigations - Kidney biopsy with immunofluorescence microscopy will show IgA deposition in the matrix.
Increased numbers of mesangial cells
Increased matrix (the cellular scaffolding that holds everything together)
What is the treatment for IgA nephropathy
Once kidneys have been damaged they can’t be repaired. Treatment focused on preventing further damage and avoiding end-stage kidney disease.
High-dose prednisolone or other immunosuppressive drugs: can reduce proteinuria and delay renal impairment
ACE-inhibitors and ARBs to reduce blood pressure.
Describe rapidly progressive glomerulonephritis (crescenteric)
Rapidly progressive glomerulonephritis (RPGN) is acute nephritic syndrome accompanied by microscopic glomerular crescent formation with progression to renal failure within weeks to months. RPGN is relatively uncommon, affecting 10 to 15% of patients with glomerulonephritis. It primarily occurs in patients aged 20 to 50 years. RPGN can be caused by anti-glomerular basement membrane antibody disease and vasculitic disorders (Granulomatosis with polyangiitis (GPA) or Microscopic polyangiitis)
Describe membranoproliferative glomerulonephritis (MPGN)
Membranoproliferative glomerulonephritis is a group of immune-mediated disorders characterised histologically by glomerular basement membrane (GBM) thickening and proliferative changes on light microscopy. It should not be confused with membranous glomerulonephritis, a condition in which the basement membrane is thickened, but the mesangium is not.
The disease is associated with hepatitis C and several autoimmune conditions including systemic lupus erythematosus (SLE).
Investigations - Typical findings on renal biopsy include:
Thickened basement membrane
Thickened mesangium
“Tram tracking” appearance
Immunofluorescence shows subendothelial deposition of IgG.